Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M34.7Revenue (TTM) $M12.2Net Margin (%)-118.4Altman Z-Score-45.5
Enterprise Value $M36.6EPS (TTM) $-1.0Operating Margin %-88.5Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-118.4Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsN
Price/Sales2.85-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-69.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M15.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARDM

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ARDM is held by these investors:



ARDM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Froehlich Juergen KurtChief Medical Officer 2017-04-04Sell3,765$1.5151.66view
Froehlich Juergen KurtChief Medical Officer 2016-10-04Sell423$6.76-66.12view
Froehlich Juergen KurtChief Medical Officer 2016-06-21Sell333$4.45-48.54view
THOMPSON VIRGILDirector 2013-12-13Sell84$6.8-66.32view
Grifols SADirector, 10% Owner 2013-08-27Sell0$0-66.32view
Boxer Capital, LLC10% Owner 2013-05-20Sell0$0-66.32view
DEF Associates Ltd.See footnote below 2012-01-01Sell0$0-66.32view
DEF Associates LPSee Footnote 1 below 2010-12-31Sell0$0-66.32view
First Eagle Value in BiotechnoSee remarks. 2009-02-23Sell0$0-66.32view
First Eagle Value in Biotechno10% Owner 2009-02-23Sell0$0-66.32view

Quarterly/Annual Reports about ARDM:

News about ARDM:

Articles On GuruFocus.com
ARADIGM ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ar Jan 19 2018 
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Jan 16 2018 
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ar Jan 16 2018 
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Aradigm Corporation Jan 14 2018 
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Aradigm Corporatio Jan 12 2018 
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ar Jan 12 2018 
Pomerantz Law Firm Announces the Filing of a Class Action against Aradigm Corporation and Certain Of Jan 11 2018 
Aradigm Reports Results of FDA Advisory Committee Meeting on Linhaliq Jan 11 2018 
Aradigm Reports Results of FDA Advisory Committee Meeting on Linhaliq Jan 11 2018 
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aradigm Corporat Jan 10 2018 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK